500 mg
Sponsors
Paradigm Biopharmaceuticals (USA) Inc., KRKA tovarna zdravil d.d. Novo mesto, Medical University Of Vienna, Instytut Pomnik Centrum Zdrowia Dziecka
Conditions
EpilepsyKnee osteoarthritisKnee osteoarthritis painTuberous Sclerosis ComplexTumors associated with Tuberous Sclerosis Complexmajor depression
Phase 2
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain
WithdrawnCTIS2022-500228-31-00
Target: 40Updated: 2022-06-27
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain
CompletedCTIS2022-500228-31-01
Start: 2023-03-31End: 2023-11-09Target: 80Updated: 2023-03-03
Randomized, placebo-controlled, double-blind and double-dummy clinical trial comparing the safety, tolerability, and efficacy of vigabatrin and rapamycin in a preventive treatment of infants with Tuberous Sclerosis Complex
RecruitingCTIS2024-513068-25-00
Start: 2021-05-20Target: 60Updated: 2025-02-25